We gratefully acknowledge the contributions of all study participants in the original clinical trial. We also extend our appreciation to the Karolinska Trial Alliance staff and research nurses for their exceptional organization of participant recruitment, scheduling, vaccination, and clinical sampling. Special thanks go to R. Varnaité, J. Emgård, N. Al-Tawil, L. Lindquist, J. Klingström and K. Loré for their dedicated efforts and contributions to the original clinical trial. We are grateful to Y. Gao for providing methodological advice. Additionally, we thank E. Alici and D. Calder for their support during the initial phase of this project.